Design-Zyme LLC

Innovative Vaccine Performance

Design-Zyme is a specialized biotech developing cutting-edge vaccines designed from inception to be safe. Our platform addresses contemporary challenges and offers effective solutions to human health challenges. Design-Zyme’s pipeline includes novel solutions for opioid use disorder (OUD), Lyme disease, fescue toxicosis, and Kush. Our platform is currently being extended to other pathogenic threats to human and animal health.

Next-Gen Vaccines

We have developed new approaches for hapten-based vaccines for Opioid Use Disorder, fescue toxicosis, and Kush as well as multivalent nanoparticle approaches to combat Lyme Disease.

Data Driven Research

Our vaccine development efforts are based on data-driven research, ensuring that our vaccines meet rigorous FDA standards for safety and efficacy.

Novel Adjuvant Solutions

Our natural adjuvant solutions are carbohydrate-based allowing for safe and effective vaccine delivery via a variety of administration routes including oral, nasal, and mucosal.

Versatile Technology

Our vaccines are modular and capable of eliciting a range of antibodies to address multivalent threats. This ensures that our vaccines result in strong immune responses to a wide range of pathogens and compounds.